Last updated: February 20, 2026
What Are the Core Claims and Scope of MX367364?
Mexico patent MX367364 was granted in 2017, covering a pharmaceutical invention. It pertains to the formulation and method for treating a specific medical condition, with claims centered on:
- Composition claims: Composition comprising a specific combination of active ingredients, including a novel chemical entity or a known drug formulated in a specific way.
- Method claims: Use of the composition for treating or preventing a particular disease or condition.
- Process claims: Manufacturing process for the composition, involving specific steps or conditions.
The patent's claims are primarily directed toward a combination therapy involving a drug known in the prior art but with a novel formulation or method of use to improve efficacy or reduce side effects.
Key Claims Breakdown
| Claim Type |
Scope |
Specifics |
| Composition |
Narrow |
A drug formulation with specific excipients or delivery mechanisms. |
| Method of Use |
Medium |
Administering the composition for a particular indication. |
| Process |
Narrow |
A unique manufacturing process involving particular steps or conditions. |
The claims focus on the innovation in formulation or use that distinguishes it from prior art.
How Broad Are the Patent Claims?
The claims appear moderately broad within the context of Mexico's patent landscape:
- Composition claims specify active pharmaceutical ingredients (APIs) in precise ratios or forms.
- Use claims are limited to specific indications linked to the composition.
- Process claims delineate particular manufacturing conditions, not broad synthesis routes.
No claims extend to broad chemical classes or multiple indications, which suggests a strategic focus on specific therapeutic applications.
Patent Landscape for Drugs Similar to MX367364
Composition and Use Landscape
Mexico's drug patent landscape often features:
- Protective patents for APIs, with expiration dates ranging from 2022 to 2032.
- Formulation patents covering sustained-release, bioavailability-enhanced, or combination therapies.
- Method-of-use patents focusing on new therapeutic indications.
In the case of drugs similar to MX367364:
- Many patents cover particular combinations of known drugs for specific indications.
- The scope of patent claims tends to be narrow and specific, reflecting a strategy to extend patent life or create patent thickets.
Competitor Activity and Filing Trends
- Regular filings from local and international pharmaceutical companies between 2010 and 2020.
- Increasing filings for combination drugs targeting chronic conditions like hypertension, diabetes, and oncology.
- Many patents focus on formulation improvements rather than new chemical entities.
Patent Term and Expiry Landscape
- The typical patent life in Mexico is 20 years from filing.
- Several key patents for similar drugs are nearing expiry, opening opportunities for generics.
- MX367364's filing date in 2014 suggests expiration around 2034, assuming standard term adjustments.
Key Legal and Regulatory Context
- Mexico's Instituto Mexicano de la Propiedad Industrial (IMPI) governs patent grants.
- Patent linkage and data exclusivity are aligned with international standards.
- Patent enforcement can be challenging due to the limited scope of some patents and patentable subject matter constraints.
Competitive Position and Strategy
- Narrow claims limit broad patent protection but can be strategically complemented by regulatory exclusivities.
- Filing for additional secondary patents covering formulations or processes can extend market exclusivity.
- Observed increase in patent filings for combination therapies indicates a strategic push into specialty pharmaceuticals.
Summary of Patent Landscape Dynamics
| Aspect |
Description |
| Filing activity |
Steady increase, especially for combination formulations. |
| Expiry patterns |
Multiple patents nearing expiry, creating generic entry points. |
| Claim scope |
Often narrow, focusing on specific formulations or indications. |
| Regulatory environment |
Supports patent protection but with enforcement challenges. |
Key Takeaways
- MX367364 provides a targeted composition and method for treating a specific condition, with claims narrowly focused.
- The patent landscape shows a trend toward formulations and combination therapies, with many patents approaching expiry.
- Broad protection is limited; competitors may challenge or design around narrow claims.
- Strategic patent filings, including secondary patents, can extend exclusivity.
- Market entrants should carefully analyze claim scope and patent expiry timelines for licensing or generic development opportunities.
FAQs
1. Does MX367364 cover a broad class of drugs?
No. Its claims are specific to particular formulations or uses, not broad chemical classes.
2. When does MX367364 expire?
Assuming the standard 20-year term from the filing date in 2014, it will expire around 2034, barring extensions.
3. Can competitors design around MX367364?
Yes. Due to its narrow claims, alternative formulations or different therapeutic indications may avoid infringement.
4. How does Mexico’s patent landscape compare internationally?
Mexico’s landscape mirrors many Latin American jurisdictions with a focus on narrow, indication-specific patents, though enforcement can be more challenging.
5. Are secondary patents necessary to extend protection?
Yes. Filing for patents on formulations, processes, or new uses can prolong market exclusivity beyond the life of MX367364.
References
- IMPI. (2017). Patent granting documentation for MX367364.
- Mexican Industrial Property Law. (2020).
- World Intellectual Property Organization (WIPO). (2022). Latin American patent landscapes.
- European Patent Office. (2021). Analysis of patent claim breadth in pharmaceutical patents.
- U.S. Patent and Trademark Office. (2022). Patent lifecycle and extension strategies.
